Following the commencement of SCH treatment, we observed an obvious reduction of tumor growth (Fig. 6D) and tumor volume (Fig. 6E) in the FOXD1-SCH group compared to FOXD1-vehicle. Here, FOXD1 is linked to spindle cell hemangioma.